Navigating Regulatory Hurdles in Drug Development
DrugBank
JUNE 18, 2025
In 2020, the FDA halted Johnson & Johnson’s COVID-19 vaccine production at a contract manufacturing facility after discovering quality control issues. Many agencies offer pre-IND meetings where companies can present their research plans, discuss potential challenges, and receive guidance on the type of data required for approval.
Let's personalize your content